GSK Wants To Know If MDL Plaintiffs Took Generic Zofran
GlaxoSmithKline urged a Massachusetts' federal court on Monday to require all plaintiffs in multidistrict litigation over anti-nausea drug Zofran to identify whether they used the brand-name drug or its generic equivalent,...To view the full article, register now.
Already a subscriber? Click here to view full article